Something in the air–Unveiling the role of atmospheric nitrogen oxides in nitrosamine formation from amine-containing APIs: Mechanistic insights and risk assessment

Read full text
Authors: Rok Grahek, Renat Selimov, Miha Drev, Holger Bauer, Paul Garbe, Brunhilde Guessregen, Joerg Schlingemann, Olivier Dirat, Krishna Veerubhotla, Ian W. Ashworth, Paula M. Tomlin
Cited by: 1
References: 29

Abstract

Atmospheric nitrogen oxides (NO x ) have emerged as a potential contributor to nitrosamine formation in active pharmaceutical ingredients (APIs) containing vulnerable amines. This study investigates the extent and mechanisms of NO x -mediated nitrosation under controlled conditions and evaluates its relevance to real-world scenarios during API manufacturing, storage and analysis. Five structurally diverse APIs were exposed to NO, NO₂, and their mixtures at concentrations representative of urban air and forcing conditions. Nitrosamine formation was confirmed for all free base APIs, whereas corresponding salts exhibited significantly lower reactivity. Overall conversion was poor, with only ∼3% of available NO x consumed, even under high humidity and elevated NOx levels. Mechanistic analysis suggests two pathways: solution-phase nitrosation in residual moisture and gas-solid surface reactions, with NO/NO₂ mixtures forming N₂O₃ as the most potent nitrosating species. Ambient air experiments revealed that small, open samples are most susceptible, while bulk storage poses minimal risk due to NO x depletion and limited replenishment. These findings highlight the importance of considering NO x exposure during analytical handling and certain manufacturing steps involving forced airflow, while supporting a low risk for typical API storage.

Fields of Study & Subjects

Atmospheric chemistry and aerosols Water Treatment and Disinfection Indoor Air Quality and Microbial Exposure

Publication details

Journal / source
Journal of Pharmaceutical Sciences
Publisher
Elsevier BV
Volume
115
Issue
6
Pages
104296–104296
Publication date
24 April 2026
Language
EN